Stefan B. Eichmuller

Heidelberg, BW, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 60 publications

The German National Strategy for Gene- and Cell-Based Therapies: Generating Impact by Employing a Novel Multi-Stakeholder Approach.

The German National Strategy for Gene- and Cell-Based Therapies: Generating Impact by Employing a Novel Multi-Stakeholder Approach.

Journal: Human gene therapy
Published: July 07, 2026

miR-155-5p drives coordinated tumor and macrophage reprogramming across multiple cancer entities.

miR-155-5p drives coordinated tumor and macrophage reprogramming across multiple cancer entities.

Journal: BMC medicine
Published: March 08, 2026

ESPEC-SUIT: a versatile and robust platform to identify and track antigen-specific T cell receptors in patients with cancer.

ESPEC-SUIT: a versatile and robust platform to identify and track antigen-specific T cell receptors in patients with cancer.

Journal: Journal for immunotherapy of cancer
Published: July 30, 2025

Latent effector T cells mediate immunotherapy responses in the bone marrow microenvironment.

Latent effector T cells mediate immunotherapy responses in the bone marrow microenvironment.

Journal: Cancer cell
Published: July 23, 2025

Neo-antigen tumor vaccination depends on CD4-licensing conveyed by adeno-associated virus like particles.

Neo-antigen tumor vaccination depends on CD4-licensing conveyed by adeno-associated virus like particles.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: February 13, 2025

Isolation of a tumor neoantigen specific CD8+ TCR from a skin biopsy of a vaccination site.

Isolation of a tumor neoantigen specific CD8+ TCR from a skin biopsy of a vaccination site.

Journal: Oncoimmunology
Published: February 04, 2025

Pushing the boundaries of radiotherapy-immunotherapy combinations: highlights from the 7th immunorad conference.

Pushing the boundaries of radiotherapy-immunotherapy combinations: highlights from the 7th immunorad conference.

Journal: Oncoimmunology
Published: December 19, 2024

Unconventional microRNA role: Enhancing the human leukocyte antigen class I antigen processing pathway via interacting with a silencer.

Unconventional microRNA role: Enhancing the human leukocyte antigen class I antigen processing pathway via interacting with a silencer.

Journal: Clinical and translational medicine
Published: June 14, 2024

MediMer: a versatile do-it-yourself peptide-receptive MHC class I multimer platform for tumor neoantigen-specific T cell detection.

MediMer: a versatile do-it-yourself peptide-receptive MHC class I multimer platform for tumor neoantigen-specific T cell detection.

Journal: Frontiers in immunology
Published: September 14, 2023

Novel microRNAs modulating ecto-5'-nucleotidase expression.

Novel microRNAs modulating ecto-5'-nucleotidase expression.

Journal: Frontiers in immunology
Published: April 03, 2023

IgE type multiple myeloma exhibits hypermutated phenotype and tumor reactive T cells.

IgE type multiple myeloma exhibits hypermutated phenotype and tumor reactive T cells.

Journal: Journal for immunotherapy of cancer
Published: September 26, 2022

MicroRNAs affecting the susceptibility of melanoma cells to CD8+ T cell-mediated cytolysis.

MicroRNAs affecting the susceptibility of melanoma cells to CD8+ T cell-mediated cytolysis.

Journal: Clinical and translational medicine
Published: August 15, 2022
Showing 1-12 of 60

Last Updated: 09/26/2026